rs149580171
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_032575.3(GLIS2):c.1464G>A(p.Leu488Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000755 in 1,588,886 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 4 hom. )
Consequence
GLIS2
NM_032575.3 synonymous
NM_032575.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.402
Publications
0 publications found
Genes affected
GLIS2 (HGNC:29450): (GLIS family zinc finger 2) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
PAM16 Gene-Disease associations (from GenCC):
- autosomal recessive spondylometaphyseal dysplasia, Megarbane typeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 16-4337413-G-A is Benign according to our data. Variant chr16-4337413-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 462720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.402 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GLIS2 | ENST00000433375.2 | c.1464G>A | p.Leu488Leu | synonymous_variant | Exon 7 of 7 | 1 | NM_032575.3 | ENSP00000395547.1 | ||
| GLIS2 | ENST00000262366.7 | c.1464G>A | p.Leu488Leu | synonymous_variant | Exon 8 of 8 | 2 | ENSP00000262366.3 | |||
| ENSG00000262712 | ENST00000574705.1 | n.406C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| PAM16 | ENST00000577031.5 | c.291+3507C>T | intron_variant | Intron 4 of 4 | 4 | ENSP00000459113.1 |
Frequencies
GnomAD3 genomes AF: 0.00421 AC: 641AN: 152156Hom.: 4 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
641
AN:
152156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000956 AC: 194AN: 203016 AF XY: 0.000621 show subpopulations
GnomAD2 exomes
AF:
AC:
194
AN:
203016
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000384 AC: 552AN: 1436612Hom.: 4 Cov.: 34 AF XY: 0.000337 AC XY: 240AN XY: 712860 show subpopulations
GnomAD4 exome
AF:
AC:
552
AN:
1436612
Hom.:
Cov.:
34
AF XY:
AC XY:
240
AN XY:
712860
show subpopulations
African (AFR)
AF:
AC:
470
AN:
33016
American (AMR)
AF:
AC:
29
AN:
42350
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25624
East Asian (EAS)
AF:
AC:
0
AN:
38604
South Asian (SAS)
AF:
AC:
7
AN:
82720
European-Finnish (FIN)
AF:
AC:
0
AN:
47742
Middle Eastern (MID)
AF:
AC:
2
AN:
5748
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1101348
Other (OTH)
AF:
AC:
37
AN:
59460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00426 AC: 648AN: 152274Hom.: 4 Cov.: 33 AF XY: 0.00426 AC XY: 317AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
648
AN:
152274
Hom.:
Cov.:
33
AF XY:
AC XY:
317
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
616
AN:
41556
American (AMR)
AF:
AC:
21
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68008
Other (OTH)
AF:
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Aug 29, 2022
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Kidney disorder Benign:1
Jun 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nephronophthisis Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nephronophthisis 7 Benign:1
Jul 19, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.